Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

Author:        

Publisher: Spandidos Publications

ISSN: 1791-2997

Source: Molecular Medicine Reports, Vol.10, Iss.2, 2014-01, pp. : 931-938

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content